![](/img/cover-not-exists.png)
Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany
R Rossaint,P Choong,K Boffard,B Riou,S Rizoli,Y Kluger,M Christensen…Volume:
10
Language:
english
Journal:
Critical Care
DOI:
10.1186/cc4516
Date:
March, 2006
File:
PDF, 12.44 MB
english, 2006